|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Net sales from products | |||||
| Net sales from services | |||||
| Total net sales | |||||
| Cost of sales | |||||
| Net sales from products | |||||
| Net sales from services | |||||
| Total cost of sales | |||||
| Gross margin | |||||
| Operating expenses: | |||||
| Selling, general and administrative | |||||
| Research and development | |||||
| Total operating expenses | |||||
| Income (loss) from operations | |||||
| Interest income, net | |||||
| Interest income | |||||
| Interest expense | |||||
| Total interest income, net | |||||
| Other income (loss), net | |||||
| Income before provision for income taxes | |||||
| Provision for (benefit from) income taxes | |||||
| Net income | |||||
| Foreign currency translation adjustments | |||||
| Foreign currency translation adjustments | |||||
| Unrealized gain on available-for-sale investments | |||||
| Comprehensive income | |||||
| Net income per common and common equivalent shares: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average number of common and common equivalent shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...